1. Maintenance Chemotherapy: An Evolving and Increasingly Acceptable Strategy in Cancer Management

   • Maurie Markman

   ReviewPaper 15 August 2010 Pages: 349 - 351

2. The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

   • Amit Mahipal
   • Mark Weiss

   Clinical Trial Report 01 September 2010 Pages: 352 - 354

3. Is Maintenance Rituximab Now Ready for PRIMA-Time?

   • Paul A. Hamlin

   Clinical Trial Report 02 September 2010 Pages: 355 - 357

4. Targeted Signal Transduction Therapies in Myeloid Malignancies

   • Emma Scott
   • Elizabeth Hexner
   • Martin Carroll

   ReviewPaper 01 September 2010 Pages: 358 - 365

5. State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship

   • Shrujal S. Baxi
   • Matthew J. Matasar

   ReviewPaper 24 August 2010 Pages: 366 - 373

6. Should Eligible Patients with T-Cell Lymphoma Receive High-Dose Therapy and Autologous Stem Cell Transplant in the Upfront Setting?

   • Carla Casulo
   • Steven Horwitz

   ReviewPaper 25 August 2010 Pages: 374 - 382

7. Post-Transplantation Lymphoproliferative Disorders: Diagnosis, Prognosis, and Current Approaches to Therapy

   • Andrew M. Evens
   • Rupali Roy
   • Leo I. Gordon

   ReviewPaper 21 October 2010 Pages: 383 - 394

   

8. Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data

   • Fredrick B. Hagemeister

   ReviewPaper 04 September 2010 Pages: 395 - 401

9. Childhood Rhabdomyosarcoma: New Insight on Biology and Treatment

   • Winston W. Huh
   • Stephen X. Skapek

   ReviewPaper 07 September 2010 Pages: 402 - 410

   

10. Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic?

    • Joy M. Fulbright
    • Winston Huh
    • Joya Chandra

    ReviewPaper 07 September 2010 Pages: 411 - 419